Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Invasive Bladder Cancer × Lidocaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 13 Neoplasms 12 Pain 11 Colorectal Neoplasms 11 Pain, Postoperative 9 Prostatic Neoplasms 7 Lung Neoplasms 7 Cancer Pain 5 Agnosia 5 Neuralgia 4 Keratosis, Actinic 4 Head and Neck Neoplasms 4 Colonic Neoplasms 4 Liver Neoplasms 3 Chronic Pain 3 Stomatitis 2 Stomach Neoplasms 2 Recurrence 2 Pilonidal Sinus 2 Oropharyngeal Neoplasms 2 Myofibroma 2 Mucositis 2 Leiomyoma 2 Ileus 2 Carcinoma, Non-Small-Cell Lung 2 Wounds and Injuries 1 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Tuberculosis 1 Thyroid Neoplasms 1

Interventions

tremelimumab 1 durvalumab 1 Sodium Chloride 1 Radiotherapy 1 Lidocaine 1 Hyperthermic Intraperitoneal Chemotherapy 1 Cystectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02924480 2022-03-09

Lidocaine

CAMC Health System

Phase NA Completed

Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡